Health ❯Healthcare ❯Diabetes ❯Type 2 Diabetes

Blood Sugar Management

Pharmaceutical Industry Medication Adherence Treatment Options Market Trends Side Effects Chronic Diseases Diabetes Research Studies Drug Safety Pharmacology

4 ARTICLES

3w ago

Amgen’s MariTide Delivers 20% Weight Loss in Phase 2 and Advances to 72-Week Phase 3 Trial

Amgen plans a 72-week pivotal study following phase 2 results that showed substantial weight loss alongside lower gastrointestinal side effects from a low-dose ramp-up.

41 ARTICLES

3mo ago

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials